###begin article-title 0
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sub>
Protein Isoaspartate Methyltransferase Prevents Apoptosis Induced by Oxidative Stress in Endothelial Cells: Role of Bcl-Xl Deamidation and Methylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: PG DI. Performed the experiments: AC RC FM IS LM. Analyzed the data: VZ. Contributed reagents/materials/analysis tools: MR MLDB SD. Wrote the paper: PG DI.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Natural proteins undergo in vivo spontaneous post-biosynthetic deamidation of specific asparagine residues with isoaspartyl formation. Deamidated-isomerized molecules are both structurally and functionally altered. The enzyme isoaspartyl protein carboxyl-O-methyltransferase (PCMT; EC 2.1.1.77) has peculiar substrate specificity towards these deamidated proteins. It catalyzes methyl esterification of the free alpha-carboxyl group at the isoaspartyl site, thus initiating the repair of these abnormal proteins through the conversion of the isopeptide bond into a normal alpha-peptide bond. Deamidation occurs slowly during cellular and molecular aging, being accelerated by physical-chemical stresses brought to the living cells. Previous evidence supports a role of protein deamidation in the acquisition of susceptibility to apoptosis. Aim of this work was to shed a light on the role of PCMT in apoptosis clarifying the relevant mechanism(s).
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 237 238 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 447 448 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 747 751 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 843 844 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 845 846 845 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 315 320 <span type="species:ncbi:9606">human</span>
Endothelial cells transiently transfected with various constructs of PCMT, i.e. overexpressing wild type PCMT or negative dominants, were used to investigate the role of protein methylation during apoptosis induced by oxidative stress (H2O2; 0.1-0.5 mM range). Results show that A) Cells overexpressing "wild type" human PCMT were resistant to apoptosis, whereas overexpression of antisense PCMT induces high sensitivity to apoptosis even at low H2O2 concentrations. B) PCMT protective effect is specifically due to its methyltransferase activity rather than to any other non-enzymatic interactions. In fact negative dominants, overexpressing PCMT mutants devoid of catalytic activity do not prevent apoptosis. C) Cells transfected with antisense PCMT, or overexpressing a PCMT mutant, accumulate isoaspartyl-containing damaged proteins upon H2O2 treatment. Proteomics allowed the identification of proteins, which are both PCMT substrates and apoptosis effectors, whose deamidation occurs under oxidative stress conditions leading to programmed cell death. These proteins, including Hsp70, Hsp90, actin, and Bcl-xL, are recognized and methylated by PCMT, according to the general repair mechanism of this methyltransferase.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
Apoptosis can be modulated by "on/off" switch partitioning the amount of specific protein effectors, which are either in their active (native) or inactive (deamidated) molecular forms. Deamidated proteins can also be functionally restored through methylation. Bcl-xL provides a case for the role of PCMT in the maintenance of functional stability of this antiapoptotic protein.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 193 196 189 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Galletti1">[1]</xref>
###xml 198 201 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Clarke1">[2]</xref>
###xml 467 473 460 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g001">Fig. 1</xref>
###xml 671 674 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Robinson1">[3]</xref>
###xml 676 679 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Aswad1">[4]</xref>
###xml 722 725 712 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Aswad1">[4]</xref>
###xml 991 994 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Reissner1">[5]</xref>
###xml 1011 1014 998 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Lanthier1">[6]</xref>
###xml 1033 1036 1020 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Pepperkok1">[7]</xref>
Protein deamidation occurs spontaneously in proteins at level of unstable Asn residues, which are flanked, on the alpha-carboxyl side, by small non-bulky residues, such as Gly, Ala, Ser or Thr [1], [2]. The deamidation mechanism entails the nucleophilic attack of the peptidyl nitrogen of the Asn+1 residue onto the beta-carbonyl carbon of the Asn, leading to the formation of an aspartyl succinimidyl (ASU) intermediate, with the elimination of the ammonia moiety. (Fig. 1). ASU itself is unstable and its ring can open on either side of the nitrogen atom, yielding either a normal peptide or an atypical isopeptide containing a beta-linked isoaspartyl residue (isoAsp) [3], [4] the latter form being generally prevalent [4]. The occurrence of such an abnormal residue can significantly alter protein structure and function, as it has been demonstrated for epidermal growth factor, calmodulin, tubulin, synapsin, eye lens crystallins, Alzheimer's beta-amyloid, tissue plasminogen activator [5] collagen type-I [6], Protein Kinase A [7] and others.
###end p 9
###begin title 10
Mechanism for deamidation of asparaginyl residues in peptides.
###end title 10
###begin p 11
(Step 1): the nitrogen of the Asn+1 residue (a Gly in the example) attacks the beta-carbonyl carbon of the Asn, thus forming the succinimidyl derivative of the peptide (ASU) with the ammonia elimination. The ASU ring can open spontaneously on either side of the nitrogen atom. In one case the alpha-aspartyl peptide is formed (Step 2). In the other case the beta-isoaspartyl peptide does occur (Step 3).
###end p 11
###begin p 12
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 566 574 562 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 672 679 668 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 848 851 844 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso1">[8]</xref>
###xml 878 881 874 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso2">[9]</xref>
###xml 978 985 974 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1272 1276 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Perna1">[10]</xref>
###xml 1286 1293 1282 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1422 1426 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1614 1618 1610 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Kim1">[11]</xref>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
###xml 1436 1440 <span type="species:ncbi:10090">mice</span>
###xml 1531 1535 <span type="species:ncbi:10090">mice</span>
Protein isoaspartyl carboxyl O-methyltransferase (PCMT; 2.1.1.77) is a S-adenosylmethionine (AdoMet)-dependent methyltransferase, which specifically recognizes and methyl esterifies the free alpha-carboxyl groups of the isoaspartyl residues, raising from asparaginyl deamidation. This enzyme, hence, promotes the conversion of the abnormal L-isoAsp residue into L-aspartyl, eliminating the isopeptide bond which alters protein conformation, thus preventing the accumulation of dysfunctional proteins. This methylation-dependent repair activity has been demonstrated in vitro, with synthetic isoAsp-containing peptides as well as with deamidated purified proteins. Various ex vivo studies confirmed that a PCMT activity is related to the processing of deamidated-isomerized proteins. For example in the erythrocytes from patients with spherocytosis [8] or with a G6PD deficiency [9] the increase in membrane protein isomerization, associated with the disease, could be monitored ex vivo by an increase in methyl ester formation in the intact erythrocytes. On the other hand, in chronic renal failure, where PCMT is inhibited by the intracellular accumulation of S-adenosylhomocysteine, membrane proteins tend to accumulate isomerized aspartyls within the red cell membrane [10]. Further in vivo studies provided evidence on the role of this enzyme in preventing the accumulation of potentially harmful damaged proteins. In PCMT knockout mice isomerized proteins increased 4-8 fold compared with the levels detected in the wild-type mice, and the knockout animals exhibited brain damage and fatal epileptic seizures [11].
###end p 12
###begin p 13
###xml 692 695 692 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso2">[9]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-DAngelo1">[12]</xref>
###xml 897 901 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-DeVry1">[13]</xref>
###xml 614 622 <span type="species:ncbi:9606">patients</span>
A number of cell stress conditions have been linked to an increased propensity of proteins to undergo deamidation. Oxidative conditions have been considered as a way through which proteins become more susceptible to deamidation. The underlying mechanism is still unclear, although the evidence suggests that oxidative conditions may induce an increased flexibility of the polypeptide backbone or a transient unfolding of proteins, allowing Asn deamidation and enhancing the formation of L-isoAsp residues. In this respect it has been shown that erythrocytes from glucose-6-phosphate dehydrogenase (G6PD)-deficient patients display a higher propensity to deamidation at membrane protein level [9]. Moreover, UV irradiation, which causes an increased formation of reactive oxygen species, leads to an increased protein deamidation in cultured melanoma cells [12]. On the other hand, analysis of the PCMT gene provided interesting clues about the regulation of this enzyme. This gene contains several motifs, as potential regulation sites in response to different stress conditions [13].
###end p 13
###begin p 14
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Huebscher1">[14]</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 356 357 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Deverman1">[15]</xref>
###xml 530 531 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 689 690 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Zhao1">[16]</xref>
###xml 919 920 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Takehara1">[17]</xref>
It has been proposed that protein methyl esterification, catalyzed by PCMT, may be able to mediate protection from apoptosis induced by Bax in a neuronal cell line [14]. This interpretation relies upon the evidence that cotransfection with a PCMT carrying vector prevents apoptosis induced by Bax, in this system. More recently it has been shown that Bcl-xL, an antiapoptotic member of the Bcl2 protein family, contains two labile asparaginyl sites which are deamidation-prone (i.e. positions 52 and 66) [15]. The deamidated Bcl-xL is not more able to block the action of pro-apoptotic proteins thus leading to cell death. A transient intracellular alkalinization has been related to Bcl-xL isomerization during cell stress [16]. It is worth noting in this respect that general alkaline pH conditions increase the tendency of labile asparaginyl residues to form ASU. Consistent with these observations the rate of Bcl-xL deamidation was found to be significantly reduced in hepatocellular carcinomas compared to normal liver tissue and this has been linked to a resistance of the transformed cells to undergo apoptosis [17].
###end p 14
###begin p 15
###xml 578 579 578 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 427 432 <span type="species:ncbi:9606">human</span>
We report here that PCMT, when overexpressed in endothelial cells, is able to prevent apoptosis induced by an oxidative treatment. Experiments using PCMT negative dominants show that the enzymatic activity must be preserved in order to exert its antiaptotic effect. In order to identify molecular mediators of apoptotic cascade involved in this mechanism, and specifically recognized and modified by PCMT, we have employed the human recombinant enzyme as a specific ligand. We thus identify in our experimental system, a number of methyltransferase targets, also including Bcl-xL. We could therefore infer the role of protein methylation in apoptotic cell death and its underlying implications.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Characterization of PCMT plasmid constructs
###end title 17
###begin p 18
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 215 222 211 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 332 336 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso3">[18]</xref>
###xml 338 342 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Kagan1">[19]</xref>
Porcine aortic endothelial cells (PAEC) were transfected with plasmid constructs carrying the PCMT sense or the antisense genes or either negative dominant mutants (Asp83-->Phe and Asp83-->Val), as described under "Methods". The site of mutagenesis, which affects a conserved residue in sequence motif I, involved in AdoMet binding [18], [19], was chosen on the basis of the information available on PCMT structure and on its catalytic mechanism.
###end p 18
###begin p 19
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
PAEC extracts were then used as a PCMT source to check whether transfection successfully produced the overexpression of the proper protein species (wild type or mutant) or, in the case of antisense, silenced the endogenous PCMT. Methyltransferase activity was assayed, according to the vapor diffusion assay procedure, in the presence of saturating concentrations of both the methyl donor AdoMet and ovalbumin, a common in vitro methyl accepting substrate.
###end p 19
###begin p 20
###xml 11 25 11 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g002">Fig. 2 panel A</xref>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
Results in Fig. 2 panel A show that PAEC transfected with the sense PCMT gene displayed an increased methyltransferase activity, compared either with the antisense PCMT transfectants or with both negative mutants.
###end p 20
###begin title 21
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
Characterization of PCMT plasmid constructs.
###end title 21
###begin p 22
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 616 621 <span type="species:ncbi:9606">human</span>
Panel A) Plasmids were transfected into endothelial cells and 48 h later methyltransferase activity was assayed using a methanol diffusion assay in the presence of saturating concentrations of the methyl donor AdoMet and ovalbumin as a methyl accepting protein. Results are given as the mean of three experiments. Error bars indicate standard deviation; (*) refer to statistically significant differences (p<0.05), as evaluated by t-test. Panel B) Cells transfected were then processed for immunoblotting with PCMT antibody. The immunoblot was reprobed for actin as a loading control. The sample "PCMT" is authentic human recombinant enzyme as a positive control. PAEc = PAE transfected with void plasmid.
###end p 22
###begin p 23
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 299 314 299 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g002">Fig. 2, panel B</xref>
###xml 729 733 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 917 921 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
The same cell extracts were then analyzed by SDS-PAGE and Western blot, using a PCMT antipeptide antibody. All transfectants carrying PCMT sense (wild type or mutants) over-expressed the relevant protein, while the protein signal was almost undetectable in those carrying the antisense counterpart (Fig. 2, panel B). These results demonstrated that PAEC, transfected with either PCMT Asp83-->Phe or Asp83-->Val plasmids effectively overexpress the relevant mutant proteins, where the conserved Asp83 residue in the consensus region I is substituted by a residue with a non polar side chain. As the result, the mutant proteins are devoid of catalytic activity. Transient transfection of PAEC with a plasmid carrying the antisense PCMT significantly lowers the activity of the endogenous methyltransferase, by critically reducing its expression. Consequently PAEC transiently transfected with plasmids carrying various PCMT constructs, can be used as a model system to study the role of PCMT on apoptosis induced by an oxidative stress.
###end p 23
###begin title 24
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PCMT overexpression prevents apoptosis induced by H2O2 treatment in endothelial cells
###end title 24
###begin p 25
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PAEC transfected with plasmids carrying PCMT wild type, mutants or antisense, were exposed to an oxidative stress brought by H2O2 treatment, as described in the experimental section. Apoptosis was monitored by the occurrence of DNA fragmentation, according to the typical DNA ladder pattern. In addition, caspase 3 activation was detected in cell extracts by SDS-PAGE Western blot analysis using an anti-caspase 3 antibody, which specifically recognizes the cleaved (activated) form of this enzyme. The activation of the apoptosis cascade was further confirmed by checking PARP cleavage, as a typical caspase 3 substrate.
###end p 25
###begin p 26
###xml 0 15 0 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g003">Fig. 3 column A</xref>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 340 341 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 342 343 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 524 525 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 526 527 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 575 579 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 609 610 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 611 612 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Fig. 3 column A shows the results of the DNA fragmentation (ladder) detection assay. Treatment with 0.1 mM H2O2 was fully effective inducing apoptosis in PAEC cells transfected with the antisense PCMT plasmid, compared with the cells overexpressing the catalytically active "sense" PCMT. The latter transfectants were in fact resistant to H2O2 treatment, up to a concentration of the oxidant in between 0.3 and 0.4 mM. As for the mutants, cells overexpressing either Asp83-->Val or Asp83-->Phe PCMT showed a sensitivity to H2O2 comparable with that observed in the antisense PCMT transfectants, since 0.1 mM H2O2 is sufficient to generate an evident DNA fragmentation.
###end p 26
###begin title 27
Effect of PCMT expression levels and mutants on apoptosis induced by oxidative stress on PAE cells.
###end title 27
###begin p 28
###xml 10 105 10 105 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoptotic DNA ladder in cells overexpressing PCMT constructs and subject to oxidative treatment</underline>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 294 308 294 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT wild type</italic>
###xml 328 332 328 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 342 344 342 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 351 353 349 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 370 372 368 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 379 381 375 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 397 510 393 506 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caspase-3 activation and PARP cleavage in cells overexpressing PCMT constructs and subject to oxidative treatment</underline>
###xml 713 714 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 715 716 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 780 789 776 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 823 825 819 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 832 834 826 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 851 853 845 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 860 862 852 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 963 1061 955 1053 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flow cytometry analysis of cells overexpressing PCMT constructs and subject to oxidative treatment</underline>
###xml 1096 1097 1088 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1098 1099 1090 1091 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1148 1162 1140 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT wild type</italic>
###xml 1182 1186 1174 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1196 1198 1188 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 1205 1207 1195 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 1221 1223 1211 1213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 1230 1232 1218 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
Column A: Apoptotic DNA ladder in cells overexpressing PCMT constructs and subject to oxidative treatment. Apoptotic DNA ladder patterns, of transfected endothelial cells stimulated with different concentrations of H2O2, were detected after transfection with plasmid void (control) or carrying PCMT wild type (sense); antisense PCMT; PCMT Asp83 -->Phe83 Mut and PCMT Asp83 -->Val83 Mut. Column B: Caspase-3 activation and PARP cleavage in cells overexpressing PCMT constructs and subject to oxidative treatment. Immunoblot developed with a polyclonal antibody against caspase-3 and PARP (a final effector of various apoptotic pathways) on transfected endothelial cells stimulated with different concentration of H2O2 after transfection with plasmid void (control) or carring PCMT wild type (sense), antisense PCMT, PCMT Asp83 -->Phe83 Mut and PCMT Asp83 -->Val83 Mut. CP is a positive control obtained by treating a parallel cell sample with cisplatin. Column C: Flow cytometry analysis of cells overexpressing PCMT constructs and subject to oxidative treatment. Cells stimulated with 0.3 mM of H2O2 after transfection with void plasmid (control), PCMT wild type (sense), Antisense PCMT, PCMT Asp83 -->Phe83 Mut. PCMT Asp83 -->Val83 Mut. PI: propidium iodide.
###end p 28
###begin p 29
###xml 244 259 244 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g003">Fig. 3 column B</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 351 352 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 506 507 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 618 619 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The enhanced sensitivity to the proapoptotic stimulus revealed by the DNA ladder assay was further confirmed by SDS-PAGE Western blot experiments, aimed at the detection of caspase-3 activation and poly (ADP-ribose) polimerase (PARP) cleavage (Fig. 3 column B). In cells transfected with antisense PCMT, indeed, apoptosis was apparent even at 0.1 mM H2O2 concentration. A similar behavior was observed in cells transfected with either PCMT mutants, in which apoptosis markers appeared already at 0.1 mM H2O2 concentration. Conversely, in the sense PCMT transfectants both markers of apoptosis were detected only at a H2O2 concentration in between 0.3 and 0.4 mM.
###end p 29
###begin p 30
###xml 166 167 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
These results, as a whole, demonstrated that PCMT overexpression is able to raise the threshold of cell sensitivity to apoptosis induced by oxidative stress up to a H2O2 concentration approaching 0.4 mM.
###end p 30
###begin p 31
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 311 312 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 691 692 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 756 757 756 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 758 759 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 771 786 771 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g003">Fig. 3 column C</xref>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1106 1107 1106 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1108 1109 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In order to quantitate the effects of the oxidative treatment on the induction of apoptosis, cells were also analyzed by flow cytometry. PAEC samples transfected with plasmids carrying wild type or antisense or negative dominant mutants of PCMT, were subject to oxidative, pro-apoptotic treatment using 0.3 mM H2O2. This value, indeed, represented a clear cut off concentration which was able to induce apoptosis only in the negative dominants (PCMT antisense or mutants), according to the markers so far employed. Results of the FACS analysis basically confirmed that overexpression of wild type PCMT prevents apoptosis induced by an oxidative stress, as judged by the appearance of a pre-G0 peak in both the antisense and mutant PCMT cell samples, upon H2O2 treatment (Fig. 3 column C). The evaluation of the area under the peaks allowed a quantitative assessment of the different cell subpopulations. Results showed that overexpression of wild type PCMT renders cells resistant to apoptosis, while a high percentage of cells transfected with antisense or either negative mutants undergo apoptosis upon H2O2 treatment.
###end p 31
###begin title 32
Accumulation of deamidated isoaspartyl-containing proteins in PCMT negative dominants
###end title 32
###begin p 33
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 488 496 488 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
It is conceivable that the reduced PCMT activity in PAEC transfected with antisense or PCMT mutants may determine a significant build up of isoaspartyl-containing damaged proteins. Therefore we attempted: a) to establish whether or not PCMT overexpression was able to prevent the accumulation of deamidated-isomerized proteins, in PAEC upon oxidative pro-apoptotic treatment; b) to quantitatively evaluate the amount of isoAsp sites in proteins extracted from these cells. To this end an in vitro assay, using recombinant PCMT, was employed.
###end p 33
###begin p 34
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g004">Fig. 4</xref>
###xml 737 744 737 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. Coli</italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Kindrachuk1">[20]</xref>
Results showed that transiently transfected PAEC were all characterized by a high content of deamidated proteins, except those overexpressing the wild type PCMT gene (Fig. 4). Therefore, the ability of PCMT to prevent apoptosis upon oxidative treatment was strictly dependent on the retention of its catalytic activity. In fact negative dominants, carrying a point mutation involving the catalytic site of the enzyme, accumulated isomerized-damaged proteins and, hence, were more sensitive to the pro-apoptotic stimulus. These results led us to exclude that PCMT may prevent apoptosis though a direct interaction of the enzymatic protein with members of the apoptotic cascade. Such a direct interaction mechanism is instead operative in E. Coli, where PCMT overexpression improved heat shock survival by a mechanism independent of its methyltransferase activity [20].
###end p 34
###begin title 35
Quantitation of the extent of protein deamidation in cells lysates after oxidative stress.
###end title 35
###begin p 36
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 87 89 87 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 96 98 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 112 114 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 120 122 116 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 218 219 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 220 221 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells transfected with PCMT wild type (sense), antisense PCMT (anti), PCMT mutants [Asp83 -->Phe83 (Phe) and Asp83-->Val83 (Val)] and endothelial cells transfected with void plasmid (PAE) were stressed with 0.3 mM of H2O2. Deamidated proteins were quantitated in each lysate preparation using recombinant PCMT. Standard deviation error bars are included for each analysis.
###end p 36
###begin p 37
More remarkably, our results demonstrate that some molecular mediators, involved in apoptosis induced by pro-oxidant conditions, are deamidated proteins, which can be methylated by PCMT, since they contains the unique feature recognized by this enzyme: the isoaspartyl residue. We were then prompted to search for substrates of PCMT whose deamidation could be favored under oxidative pro-apoptotic conditions and which could no longer be "repaired" in the negative dominants.
###end p 37
###begin title 38
Identification of PCMT substrates
###end title 38
###begin p 39
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Hurst1">[21]</xref>
###xml 692 706 692 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g005">Fig. 5 panel A</xref>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1192 1196 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1239 1243 1239 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1260 1264 1260 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1357 1361 1357 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1552 1556 1550 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 1598 1599 1596 1597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1600 1601 1598 1599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2084 2098 2082 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g005">Fig. 5 panel B</xref>
###xml 2610 2617 2608 2615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003258-t001">Table 1</xref>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
###xml 1717 1722 <span type="species:ncbi:9606">human</span>
In order to identify specific methyl accepting substrates involved in apoptosis, the purified human recombinant PCMT was cross-linked with sulfo-SBED, a trifunctional reagent containing a biotin, a sulfonated N-hydroxysuccinimide (Sulfo-NHS)active ester and a photoactivatable aryl azide. The moiety containing the active ester also exhibits a cleavable disulfide bond. A PCMT-interacting substrate is then captured by the photoreactive aryl azide moiety. The interacting complex is then isolated and the disulfide bond subsequently reduced. Upon reduction of the disulfide bond, PCMT is released and biotin is "transferred" onto the methyltransferase substrate (Label Transfer Method) [21] (Fig. 5 panel A). The biotinylated PCMT substrates can then be purified exploiting streptavidin-biotin interactions as described under "Methods" and subject to proteomic analysis. As an expression system, we chose human umbilical vein endothelial cells (HUVEC) infected with retrovirus carrying antisense-PCMT at a moi of 100. The retroviral transgene was expressed in nearly 100% of the cells, as assessed by confocal microscopy of GFP fluorescence. We used real time-PCR to analyze the silencing of PCMT gene in the cells infected with antisense-PCMT carrying virus. PCMT was effectively hypoexpressed in the antisense PCMT-transduced cells Relative expression of PCMT in the HUVEC infected with the vector carrying the antisense PCMT was 0.012 fold (+/-0.0035; standard deviation) compared to what detected in the uninfected HUVEC. HUVEC infected with retro-PCMT antisense were then treated with 0.3 mM H2O2 for 24 h. In order to identify PCMT substrates, protein extracts from these cells were incubated with biotinylated human recombinant PCMT, as above described. In order to discriminate the specifically PCMT-interacting proteins from a background of non-interacting proteins, a parallel assay was run, as a negative control, by incubating cell extracts with sulfo-SBED not cross-linked with PCMT. The resulting protein samples, enriched in PCMT substrates, were analyzed with 2D gel (Fig. 5 panel B). Protein spots, differentially expressed between sample and negative control, were considered for MALDI-TOF mass spectral analysis. Good matches were found for eight spots that were analyzed by mass spectrometry. All of them produced a good Z score, high sequence coverage and had molecular weights and isoelectric points consistent with the location of the protein on 2D gel. Several spots could not be identified, since relevant mass data did not yield a match with a high Z score or good sequence coverage (Table 1).
###end p 39
###begin title 40
Identification of PCMT substrates.
###end title 40
###begin p 41
###xml 9 84 9 84 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Experimental strategy for isolation and characterization of PCMT substrates</underline>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 560 616 560 616 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2D gel electrophoresis imaging of comparative proteomics</underline>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 712 713 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 896 903 896 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003258-t001">Table 1</xref>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Panel A: Experimental strategy for isolation and characterization of PCMT substrates. Step 1: human recombinant PCMT, purified to homogeneity, was immobilized onto sulfoSBED by N-hidroxysuccinimide chemistry; Step 2: cell extracts as a source of substrates were added and Step 3: proteins interacting with PCMT were immobilized upon UV photoactivation; Step 4: PCMT was released and biotin "transferred" onto the methyltrasferase substrate (Label Transfer Method); Step 5: purification was accomplished by exploiting streptavidin-biotin interactions. Panel B: 2D gel electrophoresis imaging of comparative proteomics. HUVEC were infected with antisense PCMT carrying retrovirus and then stressed with 0.3 mM of H2O2. Cells lysates were reacted with Sulfo-SBED previously cross-linked with recombinant PCMT (Panel B). Arrows indicate the protein spots which have been characterized as reported in Table 1. Background noise due to aspecific binding was subtracted by comparison with the 2D image obtained from a parallel sample reacted with non-cross-linked Sulfo-SBED.
###end p 41
###begin title 42
PCMT substrates identified in endothelial cells.
###end title 42
###begin p 43
###xml 46 53 46 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 117 118 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 159 164 <span type="species:ncbi:9606">human</span>
HUVEC cells were infected as described under "Methods". The antisense negative dominants were treated with 0.3 mM H2O2. PCMT ligands were isolated by means of human recombinant methyltransferase immobilized onto SulfoSBED. Purification, 2D separation and MS analysis were accomplished as detailed in the online supplemental material.
###end p 43
###begin p 44
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Galletti1">[1]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Clarke1">[2]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Aswad2">[22]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Lowenson1">[23]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Galletti2">[24]</xref>
###xml 1684 1685 1684 1685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1685 1689 1685 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Fujita1">[25]</xref>
###xml 1696 1697 1696 1697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Previous work amply demonstrated that two structural features are essential for PCMT function: a) presence of an isoAsp residue; b) recognition by the methyltransferase. As for the first feature, the most deamidation-susceptible residues are asparagines followed by non bulky residues [1], [2], [22]. As for substrate-PCMT interaction, negative structural requirements are the presence of Cys or charged residues immediately following isoAsp [23] as well as N-terminal isoAsp residues [24]. Based on these criteria we therefore carefully reviewed published sequences of all proteins substrates we had identified. Results confirmed that all proteins indeed contained at least one deamidation site, thus allowing us to predict the position at which the actual methylatable isoaspartyls may occur. Protein disulfide isomerase (accession no P30101) displays one theoretically deamidation-susceptible site at Asn199Gly, another at Asn272Ala, plus two adjacent AsnThr sites at position 88. Molecular chaperone HSP70 [accession number (AN) NP_005338.1] contains several theoretical deamidation sites including: five Asn-Ala (at position 59, 280, 367, 515, 619), two Asn-Ser (407, 646), Asn62Thr. Asn41Ser occurs in HSP90 (AN NP_031381.2). Ferrochelatase (AN NP_000131.1) displays three of such features (Asn153Thr; Asn204Ala; Asn372Gly). As for mitochondrial import receptor (AN NP_064628.1) the only theoretical deamidation site is Asn124Thr. Actin (AN P63261) contains the following theoretically deamidation-susceptible asparagines: Asn12Gly, Asn-Thr at positions 128 and 296, Asn280Ser. In addition, we identified, as a PCMT substrate, the cleaved form of the antiapoptotic protein Bcl-xL[25]. Bcl-xL deamidation sites have been experimentally and unambiguously identified by previous work, as discussed below. It is now clear that this protein undergoes deamidation at two (Asn52 and Asn66) of the three Asn-Gly sequences, which are theoretically sensitive hot spots for this post-biosynthetic modification. Present results demonstrate that this protein actually is recognized by the repair methyltransferase PCMT.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 1241 1242 1241 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Beere1">[26]</xref>
###xml 1562 1566 1562 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Arya1">[27]</xref>
###xml 1568 1572 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ruchalski1">[28]</xref>
###xml 1685 1689 1685 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Arya1">[27]</xref>
###xml 1691 1695 1691 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Beere2">[29]</xref>
###xml 1702 1703 1702 1703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1898 1899 1898 1899 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 2144 2145 2144 2145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 2303 2304 2303 2304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 2534 2535 2534 2535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 2604 2608 2604 2608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Deverman1">[15]</xref>
###xml 2765 2766 2765 2766 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 2789 2793 2789 2793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Deverman1">[15]</xref>
###xml 2797 2801 2797 2801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Deverman2">[30]</xref>
###xml 2870 2871 2870 2871 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 3128 3132 3128 3132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Zhao1">[16]</xref>
Our data demonstrate that PCMT overexpression confers resistance to apoptosis, induced by oxidative stress, in endothelial cells. Conversely, under conditions in which PCMT was suppressed, cells accumulated isoaspartyl-containing, deamidated proteins, upon oxidative stress. The identification of isoaspartyl-containing derivatives as the actual target-substrate for this protection was made possible by the utilization of PCMT as a specific enzymatic probe, which selectively recognizes the isoaspartyl moiety in deamidated proteins. In fact we were able to show that isomerized proteins increase significantly in the cells committed to apoptosis as the result of oxidative treatment. To clarify the mechanism involved in this resistance we employed a proteomics approach using, again, PCMT as a specific ligand to isolate deamidated-isomerized protein substrates. We can conclude that all the proteins we were able to isolate act as endogenous substrates for PCMT, under conditions in which cells undergo apoptosis. These substrates include various stress proteins (HSP70, HSP90, mitochondrial import receptor, protein disulfide isomerase), the cytoskeletal component actin (a long-established substrate for PCMT), ferrochelatase and Bcl-xL. The role in apoptosis of some of these proteins has been well established, in particular regarding chaperone HSP70 and HSP90 [26]. As for HSP70, this protein prevalently exerts antiapoptotic activity, both in the intrinsic and in the extrinsic pathways, according to a complex pattern throughout the apoptosis cascade [27], [28]. As for HSP90, this component, as well, is endowed with antiapoptotic activity through a multifaceted mechanism [27], [29]. Bcl-xL is perhaps the most interesting protein we were able to isolate, for at least two reasons: first it exerts powerful and direct antiapoptotic activity. Second, and more relevant to our aim, Bcl-xL undergoes deamidation in relation with cell damage, giving rise to its isoaspartyl derivative, and this process has profound implications on its functional antiapoptotic role. In fact it has been previously reported in the literature that Bcl-xL deamidation is critical in the signaling pathway leading from DNA damage to apoptosis. Data accumulating over the last few years led to the notion that Bcl-xL deamidation induces a profound structural modification, which, in turn, hampers the antiapoptotic function of this protein. In particular Deverman and coworkers used constructs where Asn52 and Asn66 in the wild type form of Bcl-xL, the two critical deamidation-susceptible asparagines, are replaced [15]. Results, as rediscussed subsequently, were consistent with the view that Asn deamidation to isoaspartate, as the real product, results in the loss of Bcl-xL function (Erratum for [15] in [30]. The mechanism for generation of the isoaspartyl derivative of Bcl-xL has been finally elucidated, as it involves an increase of the intracellular pH, consequent to cell injury, and transcriptional activation of a Na/H antiport, which constitutes a favorable microenvironment for asparaginyl deamidation through ASU formation [16].
###end p 46
###begin p 47
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 255 256 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 257 258 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso4">[31]</xref>
###xml 549 552 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso2">[9]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-DAngelo1">[12]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Galletti3">[32]</xref>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 768 776 <span type="species:ncbi:9606">patients</span>
It is worth noting that an oxidative stress, as the means we used to induce apoptosis, also represents a protein deamidation-favoring microenvironment. In this respect, it has been previously shown that a) human erythrocytes treated with either t-BHP or H2O2 accumulate deamidated isomerized proteins in the cell membrane, which are methyl esterified ex vivo by PCMT [31]; b) human erythrocytes from G6PD-deficient subjects are particularly prone to undergo deamidation at membrane protein level, upon oxidative stress, compared to normal red cells [9]; c) melanoma cells also accumulate PCMT substrates upon UV irradiation, according to a mechanism which is mediated by an oxidation [12]. Finally, we detected increased isoaspartyl formation in the erythrocytes from patients with Down Syndrome, a condition which is characterized by increased oxidative stress [32].
###end p 47
###begin p 48
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Wright1">[33]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Robinson2">[34]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Rogers1">[35]</xref>
Now a more general question arises: is the occurrence of isoaspartyls upon deamidation a built-in destruction device or, rather, a fine tuning system acting in concert with methylation? The presence of deamidation-susceptible Asn in proteins appears to be selected against during evolution [33]. Some early experimental evidence [34], [35] supports a "Molecular Clock" hypothesis. According to this model, the presence of such deamidation-susceptible Asn may account for the occurrence of time-dependent structural modifications of functional meaning. For example, in the case of triosephosphate isomerase and serine hydroxymethyltransferase, deamidation of labile asparagines residues may represent specific signals for commitment of protein to degradation.
###end p 48
###begin p 49
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Reissner1">[5]</xref>
###xml 953 957 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Weber1">[36]</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Weber2">[37]</xref>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Curnis1">[38]</xref>
###xml 1170 1171 1170 1171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1588 1589 1588 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1591 1597 1591 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g006">Fig. 6</xref>
###xml 1841 1844 1837 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Galletti1">[1]</xref>
###xml 1846 1849 1842 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Clarke1">[2]</xref>
On the other hand, it has been suggested that the non-random distribution of such labile residues in proteins may not only be related to their degradation. It has been argued that although deamidation could be actually considered as a "structural alteration", at least in some instances, the persistence of such deamidation hot spots during evolution may otherwise serve to certain functions [5]. According to this view, deamidation may be interpreted as a molecular switch that regulates partitioning over time between two molecule subpopulations of a certain protein, which are also functionally modified. The existence of PCMT, as an enzyme involved in the "repair" of the isopeptide bond resulting from Asn deamidation, is also in agreement with the latter mechanism. In this respect protein deamidation to isoaspartyl-containing products, which are susceptible to recognition and repair by PCMT, has been found to occur in the extracellular matrix [36], [37]. More recently it has been reported that deamidation of susceptible proteins in the extracellular matrix may also serve as a molecular signal to unravel new integrin binding sites [38]. Deamidation of Bcl-xL, with consequent abolishment of its antiapoptotic function, thus represents a further example of such a molecular device to change functional properties of those proteins in which it occurs. Based on present results we then propose that PCMT is involved in the modulation of the apoptotic process, by regulating the balance, within the cell, between the isoaspartyl-containing and the repaired aspartyl form of Bcl-xL (Fig. 6). The repair mechanism, as it has been shown on various models, does not consist in the restoration of the asparaginyl residues, but, rather, in the conversion of the isopeptide bond at the level of the isoAsp into a normal alpha-peptide bond [1], [2].
###end p 49
###begin title 50
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Proposed role of Bcl-xL deamidation and methylation in apoptosis.
###end title 50
###begin p 51
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Deamidation-isomerization of two critical Asn residues of Bcl-xL abolishes its antiapoptotic function. Methylation of the same residues can restore the functional integrity of Bcl-xL through repair of the isopeptide bonds. Regulation of apoptosis toward antiapoptosis is gained through fine balancing of Bcl-xL deamidation and methylation.
###end p 51
###begin p 52
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Aghdassi1">[39]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Tsutsumi1">[40]</xref>
###xml 720 721 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 870 876 870 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003258-g006">Fig. 6</xref>
###xml 1130 1131 1130 1131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Takehara1">[17]</xref>
###xml 1257 1258 1257 1258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Present results allow us to speculate on the possible implications of deamidation and methylation in the modulation of programmed cell death, under conditions in which this process is altered, such as in cancer. Some of the proteins we thus identified as PCMT substrates, which are known to be involved in apoptosis, have been implicated in pathogenesis of tumors, with particular regard to the acquisition of resistance by the transformed cell phenotypes. In this respect, it has been recently reported that HSP70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma [39]. Data also showed the role of HSP90 in the mechanism of metastasis [40] about the involvement of apoptosis in cancer, Bcl-xL perhaps provides the best example of how methylation of deamidated proteins may play a role in maintaining full functioning antiapoptotic proteins (Fig. 6). These latter, in turn, may contribute to the resistance of transformed, tumor cells, which otherwise would undergo programmed death. In line with this interpretation are previous results showing a significant reduction in the deamidation rate of Bcl-xL hepatomas, compared to normal liver tissue [17]. Our present results, on the ability of PCMT to recognize and methylate Bcl-xL, thus preserving the antiapoptotic features of this protein, in fact suggest a role of this methyltransferase as a potential target for anticancer intervention.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Materials
###end title 54
###begin p 55
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. Coli</italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 743 745 743 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 859 860 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 880 881 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 936 938 936 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
The plasmid encoding the GFP was from Stratagene (USA). E. Coli strain DH5a was used as a host for the plasmids and cloning procedures, and BMH71-18 mutS was used in the mutagenesis step (Clontech, Palo Alto, CA, USA). Bl21, Sulfo-SBED and Immunopure immobilized monomeric avidin beads were purchased from Pierce (Rockford, IL, USA). DTT, ACTH, Renin, and Angiotensin I were from Sigma (St. Louis, MO, USA). DMEM, RPMI and FBS were purchased from Life technologies (Invitrogen S.R.L., Milan, Italy). Trypsin sequencing grade (Product number V5111) was from Promega (Madison, Wisconsin, USA). Protein standards and Iodoacetamide were from BioRad laboratories (Milan, Italy). Water and Acetonitrile were HPLC grade (Sigma). S-adenosyl-L-[methyl-14C]Met [specific activity (sp. act.) 50 mCi/mmol] was purchased from Amersham International (Buckinghamshire, UK). S-adenosyl-L-[methyl-3H]Met (sp. act. 500 mCi/mmol) and S-adenosyl-L-[methyl-14C]Met (sp. act. 50 mCi/mmol) were purchased from Amersham International (Little Chalfont, Buckinghamshire, UK). All standards and reagents were from Sigma Chemical Co. and were of the purest grade available.
###end p 55
###begin title 56
PCMT clone
###end title 56
###begin p 57
###xml 64 69 <span type="species:ncbi:9606">human</span>
The pBluescript II SK-based plasmid construct pDm2X, containing human PCMT isoform II cDNA, and polyclonal antibodies against the C-terminal dodecapeptide of PCMT were generously provided by Dr. Steven Clarke (Department of Chemistry and Biochemistry and the Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA).
###end p 57
###begin title 58
Cell Culture and Transient Expression
###end title 58
###begin p 59
###xml 164 165 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 430 431 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 433 434 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
PAEC were grown on 24-well plates, in DMEM supplemented with 10% FCS and 1x penicillin/streptomycin. Cells were maintained at 37degreesC in humidified air with 5%CO2 atmosphere. For transient transfection by electroporation, PAEC growing in 150 cm2 flasks were tripsinized before confluence, collected by centrifugation, washed with PBS and resuspended in 20 mM HEPES buffer at pH 7.4, containing 137 mM NaCl, 5 mM KCl, 0.7 mM NaH2PO4 6 mM glucose, at 4degreesC.
###end p 59
###begin p 60
HUVECs from American Type Culture Collection were maintained in RPMI 1640 with 10% FCS and 2 mM glutamine, and were used at passages 5 to 10. Co-transfections were performed by mixing 15 microg of each pcDNA3.1 construct and 2 microg EGFP control. Cells were exposed to a pulsed electric field that corresponded to a field strength of 0.75 kV/cm and a duration ranging from 9 to 12 ms using electroporation cuvette and Gene Pulser II (Bio-Rad Laboratories, Hercules,. CA, USA). Samples were incubated on ice for a further 5 min, then transferred to a 10 cm diameter tissue culture dish and incubated at 37degreesC under standard growth conditions. After transfection, cells were plated for 16 h in DMEM supplemented with 10% FCS. Medium was replaced after 24 h.
###end p 60
###begin title 61
Mutagenesis
###end title 61
###begin p 62
###xml 257 258 257 258 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</underline>
###xml 255 265 255 265 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AL<underline>D</underline>VGSGSGI</named-content>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ingrosso3">[18]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Kagan1">[19]</xref>
###xml 343 378 343 378 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ggagctaaagctcttttcgtaggatctgg-3&#8242;</named-content>
###xml 403 437 403 437 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; ggagctaaagctcttgtcgtaggatctgg3&#8242;</named-content>
###xml 487 517 487 517 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-caggaaagaagatctgagcaaaag-3&#8242;</named-content>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Afl</italic>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
Mutagenesis was performed by Transformer Site-Directed Mutagenesis kit from Clontech (Palo Alto, CA). Of the three highly conserved methyltransferase sequence motifs we chose to perform mutagenesis of the invariable aspartyl site within sequence motif I (ALDVGSGSGI), involved in the AdoMet binding site [18], [19]. The mutagenesis primer was 5'-ggagctaaagctcttttcgtaggatctgg-3', (Asp replaced by Phe); 5' ggagctaaagctcttgtcgtaggatctgg3' (Asp mutated into Val). The selection primer was 5'-caggaaagaagatctgagcaaaag-3'. A unique restriction site (AflIII) was replaced with a new unique restriction site (BglII). Sequencing of double-stranded plasmid DNA by the Sanger method was used to confirm the desired nucleotide substitution.
###end p 62
###begin title 63
###xml 33 43 33 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">constructs</italic>
Characterization of PCMT plasmid constructs
###end title 63
###begin p 64
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Macfarlane1">[41]</xref>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
PCMT activity in endothelial cells transfected with vectors carrying PCMT sense or antisense or either mutants, was detected by means of the radiochemical assay described by Macfarlane, using ovalbumin as a standard methyl-accepting substrate [41]. One enzyme unit is defined as 1 pmol methyl groups transferredxmin-1.
###end p 64
###begin title 65
Plasmids
###end title 65
###begin title 66
pcDNA3.1 wild type
###end title 66
###begin p 67
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Construction of mammalian expression plasmid encoding human PCMT was subcloned from construct pDM2X used for mutagenesis, into pcDNA3.1, using the KpnI and HindIII restriction sites.
###end p 67
###begin title 68
pcDNA3.1 antisense
###end title 68
###begin p 69
The cDNA was subcloned from pcDNA3.1 wild type.
###end p 69
###begin title 70
pcDNA3.1 mut phe
###end title 70
###begin p 71
###xml 114 117 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 123 127 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
pcDNA3.1 encoding for mutated PCMT Asp83-->Phe was subcloned from construct pDM2X mut Phe into pcDNA3.1 using the KpnI and HindIII restriction sites.
###end p 71
###begin title 72
pcDNA3.1 mut Val
###end title 72
###begin p 73
pcDNA3.1 encoding for mutated PCMT Asp83-->Val was subcloned from construct pDM2X mut Val into pcDNA3.1 using the KpnI and HindIII restriction sites.
###end p 73
###begin title 74
Apoptosis Assay
###end title 74
###begin p 75
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 491 492 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 494 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 572 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 674 678 674 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
Endothelial cells were grown to 70% to 80% confluence and incubated for 18 h in the absence or the presence of 0.1, 0.2, 0.3, 0.4 or 0.5 mM H2O2. Parallel samples were treated with 35 mM Cisplatin for 18 h as a positive apoptosis control. The optimal active H2O2 concentration and exposure time were selected by determining dose-response and time curve. Under these conditions, the assay was linearly dependent on H2O2 concentration and incubation time. Longer incubation periods or higher H2O2 concentrations resulted in massive cell death. Apoptosis was assayed in vitro by a combination of three distinct approaches on endothelial cells transfected with vectors carrying PCMT sense or antisense or either mutants.
###end p 75
###begin title 76
Caspase-3 activity and PARP cleavage
###end title 76
###begin p 77
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
After oxidative injury, cells were collected and lysed in the appropriate buffer. Total cell extracts (30 to 50 microg) were electrophoresed onto a 12.5% SDS-PAGE gel system and transferred onto polyvinylidene difluoride membrane (Millipore S.p.A, Milan, Italy). Blots were incubated with a polyclonal anti-caspase-3 antibody (BD-PharMingen Milan, Italy), or mouse polyclonal antipoly (ADP-ribose) polimerase (PARP). Total active caspase-3 and PARP bands were revealed by chemiluminescence (Amersham-Pharmacia Biotech).
###end p 77
###begin title 78
DNA ladder
###end title 78
###begin p 79
Cells treated as above were harvested and DNA was extracted using the Apoptotic DNA ladder Kit (Roche Diagnostics S.p.A., Monza, Italy). DNA Ladder profiles were detected upon electrophoresis on 2% agarose gel.
###end p 79
###begin title 80
FACS scan analysis
###end title 80
###begin p 81
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Six hours after the removal of the stimulus, apoptosis was checked by detected fluorescence microscopy. FACS analysis (FACSCalibur; Becton-Dickinson, San Jose, CA, USA) was performed after treating cells pellets (approx 106 cells) with 50 microg/ml propidium iodide (PI) in 0.1% sodium citrate, in the presence of 0.1% Nonidet P40 and 100 microg/ml Dnase-free RNase A (Boeringer Mannheim, Milan Italy). Integration of area under the pre-G0 peak was measured to quantify percentages of apoptotic cells.
###end p 81
###begin title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human recombinant PCMT purification
###end title 82
###begin p 83
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. Coli</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. Coli</italic>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-MacLaren1">[42]</xref>
E. Coli strain DH5a was used for cloning and propagation of plasmid constructs. For PCMT overexpression, E. Coli strain BL21 (DE3) was transformed with pDM2x expression plasmid and grown in Luria-Bertani medium, in the presence of 100 mg/mL ampicillin. PCMT was purified from transformed bacteria basically as described by MacLaren and Clarke 1995 [42], except that the original DEAE-cellulose chromatography final step, under non-equilibrium conditions, was replaced by Q-Sepharose HP chromatography, using a Hiload 26/10 column (Pharmacia, Uppsala, Sweden). Column was equilibrated with buffer A (20 mM Tris-HCl, 0.2 mM EDTA disodium salt, 10% wt/vol glycerol, 15 mM beta-mercaptoethanol, 25 mM phenylmethylsulfonyl fluoride, 0.1 M NaCl, pH 8.0). After sample loading (10 mL, 6 mg/mL protein concentration), the column was washed with 10 volumes of buffer A (at 1 mL/min flow rate), followed by a linear gradient from 0.1 to 0.7 M NaCl over 210 minutes.
###end p 83
###begin title 84
Quantitation of isoaspartyl residues in cells lysates after oxidative stress
###end title 84
###begin p 85
###xml 80 82 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 102 104 100 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 178 179 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 691 695 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Aswad3">[43]</xref>
Cells transfected with PCMT wild type (sense), antisense PCMT, PCMT mutants (Asp83 -->Phe and PCMT Asp83-->Val) and untransfected endothelial cells were stressed with 0.3 mM of H2O2. Deamidated proteins were detected in each lysate preparation by an in vitro assay using recombinant PCMT. Damaged residues were specifically recognized and methyl esterified by PCMT, using radiolabeled AdoMet as the methyl donor, under conditions designed to insure complete labeling, on a 1:1 molar ratio, of accessible damaged residues in proteins. This method has proven highly sensitive, specific, reproducible, and particularly suitable when analysis of deamidated protein mixtures is to be carried out [43].
###end p 85
###begin title 86
Identification of PCMT substrates
###end title 86
###begin p 87
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Zhu1">[44]</xref>
In order to identify specific PCMT substrates, HUVEC were infected with PCMT antisense and stressed with 0.1 mM H2O2. Cell lysates were prepared as above and analyzed by 2D-gel electrophoresis according to Zhu et al [44].
###end p 87
###begin title 88
Generation of the retrovirus
###end title 88
###begin p 89
###xml 44 58 44 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type PCMT</italic>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 998 999 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 151 157 <span type="species:ncbi:10090">murine</span>
An 800-bp genomic sequence including either wild type PCMT or its antisense counterpart was cloned upstream from the IRES of the MSCV-IRES-GFP (MIGR) (murine stem cell virus-internal ribosome entry site-green fluorescent protein) retrovirus. Infectious defective virions were transiently produced by transfection of the 293 FT cell line with 3 plasmids: pCMV gag-pol, pCMV-VSV-G (vesicular stomatite virus envelope glycoprotein). Briefly, 293 FT cells were seeded at a concentration of 106 cells per well in 6-wells plates. The next day, 0.5 microg of each plasmid was cotransfected using Exgen reagent (Euromedex, Mundolshein, France) according to the manufacturer's recommendations. Supernatants were collected after 48, 72, and 96 h and concentrated 20-fold over an amicon membrane (Centricon Plus-80; Millipore, St-Quentin en Yvelines, France). Viral titers were determined by limiting dilution assay on NIH 3T3 cells. GFP fluorescence was analyzed by flow cytometry. Virus stocks containing 107 infectious particles per milliliter or more were used to infect HUVEC (ATCC- CRL-1730).
###end p 89
###begin title 90
Quantitative real-time -PCR
###end title 90
###begin p 91
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 303 329 303 329 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TTAAAGCCCGGAGGAAGATT3&#8242;</named-content>
RNA was extracted from the antisense PCMT-transduced cells and non-transfected HUVEC by a double Trizol- chloroform treatment and precipitated in isopropanol. Total RNA. 250 ng, was reverse transcribed using the Superscript II (Invitrogen), where the reaction mixture contained forward primer for PCMT (5'- TTAAAGCCCGGAGGAAGATT3') and, as the reverse, the oligodT examer included in the kit.
###end p 91
###begin p 92
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 184 209 184 209 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTAAAGCCCGGAGGAAGATT3&#8242;</named-content>
###xml 214 239 214 239 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCACTTCCACCTGGACCAC-3</named-content>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
The specific PCMT cDNA was then amplified in the presence of 1x SYBR green by for quantification by real time PCR. using an iCycler iQ machine (BiorRad, inc.); primers pairs used were 5'-TTAAAGCCCGGAGGAAGATT3' and 5'-ATCACTTCCACCTGGACCAC-3, designed to amplify 169 bp region of PCMT cDNA.
###end p 92
###begin p 93
###xml 90 94 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 131 135 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 294 299 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 356 360 348 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</sub>
###xml 356 360 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PCMT</sub></italic>
###xml 363 368 355 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</sub>
###xml 363 368 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>GAPDH</sub></italic>
###xml 397 401 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 586 590 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 629 637 609 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">infected</sub>
###xml 645 655 621 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uninfected</sub>
###xml 703 716 679 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 737 750 705 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 797 801 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCMT</italic>
###xml 824 837 784 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 884 888 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003258-Ponchel1">[45]</xref>
Relative expression was calculated using the DeltaCt method. To determine the quantity of PCMT transcript present in the antisense-PCMT-infected HUVEC, relative to uninfected ones, their respective Ct values were first normalized by subtracting the Ct value obtained from the evaluation of the GAPDH transcript, chosen as an housekeeping gene (DeltaCt = CtPCMT-CtGAPDH). The relative abundance of PCMT transcript in the infected HUVEC compared with uninfected cells was calculated by subtracting the normalized Ct values obtained for uninfected cells from those obtained from antisense-PCMT infected cells (DeltaDeltaCt = DeltaCtinfected-DeltaCtuninfected; the relative expression was then determined (2-DeltaDeltaCt). The the value of 2-DeltaDeltaCt>1 reflects increased expression of the target PCMT gene, and a value of 2-DeltaDeltaCt<1 points to a decrease in the gene expression [45].
###end p 93
###begin title 94
Crosslinking reaction
###end title 94
###begin p 95
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 579 580 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PCMT was dissolved at 1 mg/mL in phosphate buffer (0.1 M phosphate, 0.18 M Na, pH 7.5). 1.12 mg of SulfoSBED was weighed and dissolved in DMSO under subdued light immediately before use. PCMT and sulfoSBED solutions were combined and maintained under subdued light with aluminum foil wrapping for 30-60 min at room temperature and nonreacted SulfoSBED was removed from solution by dialysis using Slide-A-Lyzer Dialysis Cassette (Pierce). 5 mg of proteins extracted from HUVEC cells line after infection with PCMT antisense carrying retrovirus and treated for 24 h with 0.1 mM H2O2, were dissolved in 0.5 ml PBS and incubated at room temperature for 3-5 minutes with the biotinylated complex. A 365 nm UV lamp (Rad-Free Model RF UV-365, Schleicher and Schuell, Keene, NH, USA), held at 5 cm distance from sample solutions, was used to activate the arylazide portion of the crosslinker. Samples were reduced by adding DTT to a final concentration of 50 mM and incubating for 1 h at room temperature.
###end p 95
###begin title 96
Binding biotinylated proteins
###end title 96
###begin p 97
Avidin affinity capture of biotinylated species was performed using immobilized monomeric avidin. Small batches (typically 100 microl) of beads in 50% aqueous suspension (MagPrep Streptavidin Beads purchased from Novagen, Merck chemicals Ltd, Nottingham, UK) were prepared for use into a clean 1.5 ml microcentrifuge tube and placed in magnetic tube rack, following wash with 400 microl of 0.1 M phosphate buffer (pH 7.5, 0.18 M Na) and the aqueous supernatant removed. The beads were washed twice and resuspended to their original volume then incubated for 30 min at RT with purified biotinylated target protein. After the binding, the excess of protein was taken away by magnetizing the beads and removing the aqueous phase.
###end p 97
###begin title 98
2D analysis and MALDI-TOF
###end title 98
###begin p 99
Gels were stained with Coomassie blue and spots of interest were identified by comparing gel images as appropriate. Spots of interest were then cut and submitted to the Proteomics Core. The samples were transferred to the MassPrep station for automated in-gel protein digestion, following the protocol included with the WinPREP Multiprobe II software (WinPREP Multiprobe II; Perkin Elmer, Massachussets, USA). Briefly, gel pieces were de-stained with ammonium bicarbonate/acetonitrile and reduced with dithiothreitol. The reducing mixture was removed and iodoacetamide in ammonium bicarbonate added and incubated for 20 min at 37degreesC. The alkylation solution was removed, followed by washing with ammonium bicarbonate/water and dehydration with acetonitrile. In-gel digestion of the extracted proteins was carried out with 6 ng/microL trypsin in 50 mM ammonium bicarbonate for 5 h at 37degreesC. The digested peptides were extracted in a mixture of 1% formic acid/2% acetonitrile and applied onto a stainless steel MALDI plate (Micromass). Mass spectra of the resulting peptides were recorded on the MALDI-TOF spectrometer in reflectron mode (Perkin Elmer Mass Prep Station; Micromass Maldi-TOF RL). Prior to data collection, calibration was performed with Angiotensin I (Average molecular mass 1296.5 Da), Renin (Average molecular mass 1759.0, Da), and ACTH 18-39 clip (adenocorticotropic hormone clip 18-39, average molecular mass 2465.199 Da). Sofware MassLynx 4.0 (Micromass); ProteinLynx 2.0 (Micromass) was used for processing, background subtraction, and some supplemental analysis. Resulting peptides were matched with their corresponding proteins with XProteo (XProteo: fast, reliable protein identification), by searching the non-redundant database maintained at the NCBI (). In order to produce a putative protein identification and score, the following parameters were used for search: mass tolerance 0.07 Da, incomplete cleavages allowed, alkylation of Cys and oxidation of Met were considered as possible modifications. Percentage of sequence coverage (%) was indicated for each protein assignment. Z-score is defined as the distance to the population mean in unit of standard deviation. It also corresponds to the percentile of the search in the random match population (according to ProFound - Peptide Mapping Version 4.10.5 - The Rockefeller University Edition).
###end p 99
###begin p 100
The authors wish to thank Dr Vincenzo Nigro, Professor of General Pathology at S.U.N., for helpful hints and for kindly reviewing the manuscript.
###end p 100
###begin title 101
References
###end title 101
###begin article-title 102
Protein damage and methylation-mediated repair in the erytrocyte.
###end article-title 102
###begin article-title 103
Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair.
###end article-title 103
###begin article-title 104
Molecular clocks.
###end article-title 104
###begin article-title 105
Isoaspartate in peptides and proteins: formation, significance, and analysis.
###end article-title 105
###begin article-title 106
Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitions signals?
###end article-title 106
###begin article-title 107
Protein L-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration.
###end article-title 107
###begin article-title 108
Intracellular distribution of mammalian Protein Kinase A catalytic subunit altered by conserved Asn2 deamidation.
###end article-title 108
###begin article-title 109
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: evidence for differentiated splenic conditioning role.
###end article-title 109
###begin article-title 110
Protein methylation as a marker of aspartate damage in G6PD-deficient erythrocytes. Role of oxidative stress.
###end article-title 110
###begin article-title 111
Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure.
###end article-title 111
###begin article-title 112
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice.
###end article-title 112
###begin article-title 113
UVA irradiation induces L-isoaspartyl formation in melanoma cell proteins.
###end article-title 113
###begin article-title 114
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human gene encoding the protein repair L-isoaspartyl (D-aspartyl) O-methyltransferase.
###end article-title 114
###begin article-title 115
Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis.
###end article-title 115
###begin article-title 116
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.
###end article-title 116
###begin article-title 117
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.
###end article-title 117
###begin article-title 118
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 37 42 <span type="species:ncbi:9606">human</span>
Suppression of Bcl-xL deamidation in human hepatocellular carcinomas.
###end article-title 118
###begin article-title 119
###xml 64 69 <span type="species:ncbi:9606">human</span>
Sequence of the D-aspartyl/L-isoaspartyl methyltransferase from human erythrocytes: common sequence motif for protein, DNA, RNA and small molecule S-adenosylmethionine-dependent methyltransferase.
###end article-title 119
###begin article-title 120
Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes.
###end article-title 120
###begin article-title 121
###xml 56 72 <span type="species:ncbi:562">Escherichia coli</span>
Overexpression of L-isoaspartate O-methyltransferase in Escherichia coli increases heat shock survival by a mechanism independent of methyltransferase activity.
###end article-title 121
###begin article-title 122
Mass spectrometric detection of affinity purified crosslinked peptides.
###end article-title 122
###begin article-title 123
Methods for analysis of deamidation and isoaspartate formation in peptides and proteins.
###end article-title 123
###begin article-title 124
Identification of isoaspartyl-containing sequences in peptides and proteins that are usually poor substrates for the class II protein carboxyl methyltransferase.
###end article-title 124
###begin article-title 125
Enzymatic methyl esterification of synthetic tripeptides: structural requirements of the peptide substrate. Detection of the reaction products by fast-atom-bombardment mass spectrometry.
###end article-title 125
###begin article-title 126
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Acceleration of apoptotic cell death after the cleavage of Bcl-xL protein by caspase-3-like proteases.
###end article-title 126
###begin article-title 127
Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways.
###end article-title 127
###begin article-title 128
Heat shock genes-integrating cell survival and death.
###end article-title 128
###begin article-title 129
Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation.
###end article-title 129
###begin article-title 130
"The stress of dying": the role of heat shock proteins in the regulation of apoptosis.
###end article-title 130
###begin article-title 131
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage (Erratum).
###end article-title 131
###begin article-title 132
Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress.
###end article-title 132
###begin article-title 133
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down Syndrome.
###end article-title 133
###begin article-title 134
Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins.
###end article-title 134
###begin article-title 135
Deamidation of glutaminyl and asparaginyl residues in peptides and proteins.
###end article-title 135
###begin article-title 136
Degradation of structurally characterized proteins injected into HeLa cells.
###end article-title 136
###begin article-title 137
Injury-induced enzymatic methylation of aging collagen in the extracellular matrix of blood vessels.
###end article-title 137
###begin article-title 138
Detection and characterization of a protein isoaspartyl methyltransferase which becomes trapped in the extracellular space during blood vessel injury.
###end article-title 138
###begin article-title 139
Spontaneous formation of L-isoaspartate and gain of function in fibronectin.
###end article-title 139
###begin article-title 140
Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma.
###end article-title 140
###begin article-title 141
Extracellular heat shock protein 90: A role for a molecular chaperone in cell motility and cancer metastasis.
###end article-title 141
###begin article-title 142
Inhibitors of cyclic nucleotide phosphodiesterases inhibit protein carboxyl methylation in intact blood platelets.
###end article-title 142
###begin article-title 143
###xml 33 38 <span type="species:ncbi:9606">human</span>
Expression and purification of a human recombinant methyltransferase that repairs damaged proteins.
###end article-title 143
###begin article-title 144
Methods for analysis of deamidation and isoaspartate formation in peptides and proteins.
###end article-title 144
###begin article-title 145
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain.
###end article-title 145
###begin article-title 146
Real-Time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletion.
###end article-title 146
###begin p 147
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 147
###begin p 148
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by Grant 2005062199_003 from M.I.U.R.-P.R.I.N. to D. Ingrosso and by Grant 2004057129_003 from M.I.U.R.-P.R.I.N. to P.Galletti.
###end p 148

